![Marcia Belvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcia Belvin
Chief Tech/Sci/R&D Officer at
CYTOMX THERAPEUTICS, INC.
Net worth: 593 737 $ as of 31/05/2026
Profile
Marcia P.
Belvin is currently Chief Scientific Officer & Senior Vice President at CytomX Therapeutics, Inc., a position held since 2022.
Education includes an undergraduate degree from Harvard University and a doctorate from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 164,927 ( 0.08% ) | 593 737 $ | 31/05/2026 |
Marcia Belvin active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2020 |
Training of Marcia Belvin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Marcia Belvin
